Understanding HIV risks and prevention among women who use drugs in the Southern U.S.
HIV risk, PrEP disparities, and stigma among Women who use Drugs in the U.S. South, with attention to race and sexual orientation: A mixed-method intersectionality study
This study is looking at the specific challenges that cisgender women who use drugs face in the Southern U.S. when it comes to preventing HIV, especially how things like race and sexual orientation can make it harder for them to get the help they need, like PrEP. The goal is to understand their experiences better so we can create better support and resources for them.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lsu Health Sciences Center NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-10881975 on NIH RePORTER |
What this research studies
This research investigates the unique challenges faced by cisgender women who use drugs in the Southern United States regarding HIV risk and prevention. It focuses on how factors like race and sexual orientation contribute to stigma and affect access to HIV prevention resources, specifically PrEP (pre-exposure prophylaxis). By employing a mixed-method approach, the study aims to identify barriers and facilitators to PrEP uptake and to understand the intersectional experiences of these women. The findings will help develop targeted interventions to reduce stigma and improve healthcare access for these marginalized groups.
Who could benefit from this research
Good fit: Ideal candidates for this research are cisgender women who use drugs and are at risk for HIV, particularly those from marginalized racial and sexual minority backgrounds.
Not a fit: Patients who do not identify as women or who do not use drugs may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to HIV prevention resources and better health outcomes for women who use drugs.
How similar studies have performed: Previous research has shown success in addressing HIV prevention disparities among marginalized populations, indicating that this approach has potential for impactful outcomes.
Where this research is happening
New Orleans, United States
- Lsu Health Sciences Center — New Orleans, United States (Active)
Researchers
- Principal investigator: Glick, Jennifer L — Lsu Health Sciences Center
- Study coordinator: Glick, Jennifer L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.